GlaxoSmithKline PLC Analysis
| Analyst Ratings |
|
Average Target Price
|
44.29
|
|
Average Rating
|
3.20
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
3
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
0.78
|
0.00
|
-0.78
|
-100.00%
|
|
2022-12-31
|
0.58
|
0.00
|
-0.58
|
-100.00%
|
|
2022-09-30
|
0.96
|
1.10
|
0.14
|
14.58%
|
|
2022-06-30
|
0.73
|
0.87
|
0.14
|
19.18%
|
|
2022-03-31
|
0.93
|
1.09
|
0.16
|
17.20%
|
|
2021-12-31
|
0.81
|
0.86
|
0.05
|
6.17%
|
|
2021-09-30
|
1.01
|
1.26
|
0.25
|
24.75%
|
|
2021-06-30
|
0.64
|
0.98
|
0.34
|
53.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
3.06
|
|
2021-12-31
|
3.89
|
|
2020-12-31
|
3.55
|
|
2019-12-31
|
3.16
|
|
2018-12-31
|
3.21
|
|
2017-12-31
|
2.89
|
|
2016-12-31
|
2.74
|
|
2015-12-31
|
6.37
|
|
2014-12-31
|
2.74
|
|
2013-12-31
|
3.32
|
|
2012-12-31
|
3.61
|
|
2011-12-31
|
3.34
|
|
2010-12-31
|
1.24
|
|
2009-12-31
|
4.28
|
|
2008-12-31
|
4.08
|
|
2007-12-31
|
3.95
|
|
2006-12-31
|
4.14
|
|
2005-12-31
|
3.19
|
|
2004-12-31
|
2.88
|
|
2003-12-31
|
2.67
|
|
2002-12-31
|
2.35
|
|
2001-12-31
|
3.13
|
|
1999-12-31
|
0.89
|
|
1998-12-31
|
2.66
|
|
1996-12-31
|
1.74
|
|
1995-12-31
|
0.70
|
|
1994-12-31
|
2.08
|